Archives
-
MAPK10-Mediated KRT16 Degradation Limits NSCLC Metastasis
2026-07-07
This study identifies mitogen-activated protein kinase 10 (MAPK10) as a suppressor of non-small cell lung cancer (NSCLC) metastasis by promoting phosphorylation-dependent ubiquitination and degradation of keratin 16 (KRT16). These mechanistic insights establish the MAPK10/KRT16/RNF213 axis as a potential biomarker and therapeutic target, with significant implications for personalized NSCLC treatment strategies.
-
ATP Solution (100 mM): Precision Substrate for Kinase & mRNA
2026-07-07
ATP Solution (100 mM) is a high-purity Adenosine-5'-triphosphate substrate critical for kinase reactions, in vitro transcription, and phosphorylation assays. The product's ≥99% purity and nuclease-free formulation ensure reproducible, sensitive results in advanced molecular workflows.
-
Itraconazole: Advancing Translational Strategies Against Can
2026-07-06
This in-depth article dissects the multifaceted role of itraconazole—a triazole antifungal agent—in overcoming Candida biofilm-driven resistance. It integrates mechanistic insight, workflow guidance, and translational foresight, offering actionable intelligence for researchers tackling the evolving challenge of persistent fungal infections.
-
Refining In Vitro Drug Response Metrics in Cancer Research
2026-07-06
Schwartz’s dissertation redefines how anti-cancer drug effects are measured in vitro by separating proliferative arrest from cell death. This advance enables more precise interpretation of drug efficacy, informing translational and preclinical research workflows.
-
ECL Chemiluminescent Substrate Detection Kit: Advanced HRP C
2026-07-05
Unlock ultra-sensitive detection of low-abundance proteins with the ECL Chemiluminescent Substrate Detection Kit (Hypersensitive). Discover how this APExBIO innovation streamlines Western blot workflows, extends signal duration, and delivers lower background for reliable, cost-effective immunoblotting.
-
Gallein: Applied G Protein βγ Inhibitor Workflows & Innovati
2026-07-04
Gallein, a selective G protein βγ subunit inhibitor from APExBIO, offers researchers robust control over GPCR signaling in cancer, immunology, and metabolic models. This article unpacks practical protocols, advanced use-cases, and critical troubleshooting approaches that maximize the translational impact of Gallein across experimental domains.
-
iTBS Improves Motor and Molecular Pathology in SCA3/MJD Mice
2026-07-03
This study demonstrates that intermittent theta-burst stimulation (iTBS) significantly improves motor coordination and modulates molecular pathologies in a mouse model of Spinocerebellar ataxia type 3 (SCA3/MJD). The findings highlight iTBS as a promising non-invasive neuromodulatory intervention targeting neuroinflammation and autophagy, with superior efficacy over continuous TBS paradigms.
-
Boc-D-FMK: Pan-Caspase Inhibitor Workflows for Apoptosis Res
2026-07-03
Boc-D-FMK from APExBIO is a robust, cell-permeable pan-caspase inhibitor trusted for precise control of apoptotic signaling in both inflammation and cell death studies. This article delivers actionable workflows, protocol enhancements, and troubleshooting tips, empowering researchers to achieve reproducible results in demanding experimental models.
-
MALAT1 Regulates Cell Fate via miR-135b-5p/GPNMB in Parkinso
2026-07-02
Lv et al. (2021) reveal that the long non-coding RNA MALAT1 modulates cell proliferation and apoptosis in MPP+-induced Parkinson’s disease cell models through the miR-135b-5p/GPNMB axis. This work clarifies a novel regulatory pathway in PD cellular pathology and supports rational biomarker investigation.
-
Temafloxacin: Mechanistic Insights and Advanced Research App
2026-07-02
Explore Temafloxacin, a fluoroquinolone broad-spectrum antibacterial agent, through an in-depth mechanistic and translational lens. This article offers novel perspectives on molecular targeting, experimental design, and the intersection with contemporary antibiotic optimization science.
-
Cell Surface RNA-Binding Protein Domains Enable Peptide Entr
2026-07-01
This study reveals that RNA-binding proteins (RBPs) and glycoRNAs form specialized nanoclusters on the cell surface, serving as entry sites for cell-penetrating peptides such as TAT. These findings expand our understanding of the cell surface interactome and suggest new routes for targeted delivery and surface proteomics.
-
Protease Inhibitor Cocktail (100X): Safeguarding Proteome In
2026-07-01
Explore the science and advanced applications of Protease Inhibitor Cocktail (100X) for robust protein degradation prevention in molecular assays. Uncover practical insights from recent research and distinct workflow optimizations.
-
Treponema pallidum Triggers Hepatocyte Apoptosis via Mitocho
2026-06-30
This study elucidates how Treponema pallidum induces intrinsic apoptosis in hepatocytes by promoting mitochondrial reactive oxygen species (ROS) accumulation and cardiolipin peroxidation. The findings clarify the mitochondrial mechanisms underlying syphilitic liver injury and highlight potential targets for intervention.
-
EPZ5676: Precision DOT1L Inhibitor Workflows for Leukemia Re
2026-06-30
EPZ5676 is a gold-standard DOT1L inhibitor, enabling selective, high-fidelity epigenetic modulation in MLL-rearranged leukemia and beyond. This article presents advanced experimental workflows, troubleshooting strategies, and actionable insights for maximizing reproducibility and biological impact with EPZ5676 in histone methylation and cytotoxicity assays.
-
Adenosine Triphosphate (ATP): Precision Tools for Mitochondr
2026-06-29
Explore how Adenosine Triphosphate (ATP) empowers advanced mitochondrial metabolism research, with a focus on post-translational regulation and assay optimization. Discover unique insights that move beyond standard ATP applications.